SCHEMBL27119385

SCHEMBL27119385

COc1ccc(-c2ncnc(Nc3ccccc3)n2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.49
▸ TEK Q02763 1/20 0.47
▸ TBK1 Q9UHD2 2/20 0.46
▸ BCL6 P41182 1/20 0.46
▸ FGFR2 P21802 1/20 0.45
▸ FGFR3 P22607 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ BRAF P15056 1/20 0.44
▸ MKNK1 Q9BUB5 1/20 0.42
▸ MKNK2 Q9HBH9 1/20 0.42
▸ CDK9 P50750 3/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ TAOK1 Q7L7X3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27112164 0.81 TEK (0.51) TEKTBK1BCL6FGFR2FGFR3
SCHEMBL27116469 0.79 PRKCA (0.63) MEN1KMT2ACDK5CAMK2D
SCHEMBL28185425 0.78 BCL6 (0.61) TEKTBK1BCL6FGFR3MEN1
SCHEMBL27843906 0.78 PIK3CA (0.53) TBK1MEN1USP2KMT2ACDK9
SCHEMBL14214623 0.77 KDR (0.55) TBK1MEN1KMT2ACDK9CSF1R
SCHEMBL27890451 0.76 CYP1A2 (0.55) TEKTBK1FGFR2FGFR3MEN1
SCHEMBL2459757 0.74 TEK (0.64) TEKBCL6FGFR2FGFR3USP2
SCHEMBL27824876 0.73 TBK1 (0.47) TBK1MEN1USP2KMT2ABRAF
SCHEMBL2330210 0.73 TBK1 (0.51) TBK1FGFR2FGFR3MEN1USP2
SCHEMBL29636445 0.72 KMT2A (0.54) MEN1USP2KMT2AACP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 — — WO disclosed
Send feedback